VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
TLSA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
TLSATiziana Life Sciences Ltd
$0.69$44M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksTLSARevenue History

TLSA logoTiziana Life Sciences Ltd (TLSA) Revenue History

Annual and quarterly revenue from 1998 to present

TTM Revenue$0
YoY Growth—
Q2 2026$0
Revenue CAGR
3Y—
→
5Y—
→
10Y—
Best Fiscal Year$405K (2006)
Best Quarter$203K (Q4 2006)

TLSA Revenue Over Time (1998–2025)

TLSA Revenue Growth History

5 of 9 years with positive growth
Annual Revenue Growth · Each cell = one fiscal year
1998—
1999—
2000—
2001—
2002—
2003—
2004—
2005+17.2%
2006+249.1%
2007-84.2%
2008+43.8%
2009-39.1%
2010+234.5%
2011-143.8%
2012+100.0%
2013—
2014-100.0%
2015—
2016—
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—
2025—
FY1998 revenue growth
N/A
FY1999 revenue growth
N/A
FY2000 revenue growth
N/A
FY2001 revenue growth
N/A
FY2002 revenue growth
N/A
FY2003 revenue growth
N/A
FY2004 revenue growth
N/A
FY2005 revenue growth
+17.2%
FY2006 revenue growth
+249.1%
FY2007 revenue growth
-84.2%
FY2008 revenue growth
+43.8%
FY2009 revenue growth
-39.1%
FY2010 revenue growth
+234.5%
FY2011 revenue growth
-143.8%
FY2012 revenue growth
+100.0%
FY2013 revenue growth
N/A
FY2014 revenue growth
-100.0%
FY2015 revenue growth
N/A
FY2016 revenue growth
N/A
FY2017 revenue growth
N/A
FY2018 revenue growth
N/A
FY2019 revenue growth
N/A
FY2020 revenue growth
N/A
FY2021 revenue growth
N/A
FY2022 revenue growth
N/A
FY2023 revenue growth
N/A
FY2024 revenue growth
N/A
FY2025 revenue growth
N/A
DeclineStrong growth
Best: +249.1% (FY2006)Worst: -143.8% (FY2011)
Recent Quarterly Revenue & YoY Growth
QuarterRevenueYoY
Q2 2026$0—
Q4 2025$0—
Q2 2025$0—
Q4 2024$0—
Q2 2024$0—
Q4 2023$0—
Q2 2023$0—
Q4 2022$0—

TLSA Revenue Analysis (1998–2025)

Current Revenue & Growth

As of November 8, 2026, Tiziana Life Sciences Ltd (TLSA) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q2 2026) recorded $0 in revenue

Historical Growth Trajectory

TLSA's historical revenue data shows various trends over time. Tiziana Life Sciences Ltd's highest annual revenue of $405,000 was recorded in 2006.

Peer Comparison

Compared to Healthcare sector peers — including ARCT (-72.9% YoY), KYMR (+133.7% YoY), and RCUS (-58.3% YoY). Compare TLSA vs ARCT →

TLSA Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
TLSA logoTLSACurrent$0---
ARCT logoARCT$67M-72.9%+47.8%-111.5%
KYMR logoKYMR$39M+133.7%+2.9%-891.3%
RCUS logoRCUS$247M-58.3%+25.9%-156.3%
Best in groupLowest in group

TLSA Historical Revenue Data (1998–2025)

1–15 of 28 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2025$0-$0-$-21,132,000-
2024$0-$0-$-15,794,000-
2023$0-$0-$-17,984,000-
2022$0-$-14,586,000-$-14,586,000-
2021$0-$0-$-36,925,374-
2020$0-$0-$-38,122,268-
2019$0-$-250,044-$-9,963,202-
2018$0-$-16,000-$-9,910,859-
2017$0-$-10,677-$-8,246,000-
2016$0-$-8,791-$-7,288,000-
2015$0-$0-$-8,905,940-
2014$0-100.0%$0-$-2,762,000-
2013$3K-$3K100.0%$-254,845-8494.8%
2012$0+100.0%$0-$-458,000-
2011$-82,000-143.8%$-82,000100.0%$-289,000352.4%
Consensus & Technical Research Suite
Open TLSA Terminal

TLSA Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

28+ years return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

TLSA — Frequently Asked Questions

Quick answers to the most common questions about buying TLSA stock.

Is TLSA's revenue growth accelerating or slowing?

TLSA TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.

What is TLSA's revenue history from 1998 to 2026?

Tiziana Life Sciences Ltd (TLSA) revenue history spans 1998 to 2026. TTM revenue as of 2026 is $0.00, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.

What is TLSA's long-term revenue growth rate (CAGR)?

Tiziana Life Sciences Ltd's 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for TLSA.

Why does TLSA's quarterly revenue fluctuate?

TLSA quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Tiziana Life Sciences Ltd's revenue data from 1998 to 2026 shows full historical quarterly detail on this page.

How is TLSA's revenue distributed by segment?

TLSA reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.

How does TLSA's revenue compare to industry peers?

Tiziana Life Sciences Ltd (TLSA) with TTM revenue of $0.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.